Phathom Pharmaceuticals
PHAT
PHAT
94 hedge funds and large institutions have $237M invested in Phathom Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
10.92% less ownership
Funds ownership: 80.91% → 69.98% (-11%)
32% less capital invested
Capital invested by funds: $349M → $237M (-$112M)
Holders
94
Holding in Top 10
4
Calls
$1.46M
Puts
–
Top Buyers
| 1 | +$11.2M | |
| 2 | +$5.87M | |
| 3 | +$3.94M | |
| 4 |
NM
Newtyn Management
New York
|
+$2.63M |
| 5 |
BlackRock
New York
|
+$2.05M |
Top Sellers
| 1 | -$9.35M | |
| 2 | -$8.99M | |
| 3 | -$1.07M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$595K |